Yuval Cohen was appointed CEO of Corbus Pharmaceuticals.
2 reports, 1 independent
Updated Aug 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Yuval Cohen was appointed CEO of Corbus Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Corbus Pharmaceuticals
company in Norwood, United States
Nothing else this week.
-
Yuval Cohen
researcher
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireCorbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Phase 1/2 dose expansion data for Nectin-4 targeting ADC CRB-701 to be presented at ESMO 2025 Init
- Unknown outlet